CA Patent

CA2574326A1 — Novel form of celecoxib

Assigned to Pliva Hrvatska doo · Expires 2006-05-18 · 20y expired

What this patent protects

The invention describes a novel solid state form of a pharmacologically active benzenesulfonamide derivative. Also described is a process for the preparation of the novel form and pharmaceutical compositions containing it for use in the treatment or prevention of painful inflamma…

USPTO Abstract

The invention describes a novel solid state form of a pharmacologically active benzenesulfonamide derivative. Also described is a process for the preparation of the novel form and pharmaceutical compositions containing it for use in the treatment or prevention of painful inflammatory conditions.

Drugs covered by this patent

Patent Metadata

Patent number
CA2574326A1
Jurisdiction
CA
Classification
Expires
2006-05-18
Drug substance claim
No
Drug product claim
No
Assignee
Pliva Hrvatska doo
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.